---
title: "CDKL5"
date: 2023-05-11 00:00:00
layout: post
categories: Gene
summary: "## Information about Gene CDKL5"
tags: ['CDKL5', 'NeurodevelopmentalDisorder', 'GeneMutation', 'BrainFunction', 'Treatment', 'Prognosis', 'DrugResponse', 'DiagnosticTest']
---

## Information about Gene CDKL5

### Genetic Position and Pathology
The CDKL5 gene is located on the X chromosome at the position Xp22.13. Mutations in the CDKL5 gene cause a rare X-linked neurodevelopmental disorder called CDKL5 deficiency disorder (CDD), which is characterized by early-onset seizures, severe intellectual disability, and developmental delay.

### Function
The CDKL5 gene codes for a protein kinase that is involved in brain development and function. The protein helps regulate the activity of other proteins that control gene expression and synaptic function in the brain.

### External IDs and Aliases
- HGNC: 1779
- NCBI Entrez: 6792
- Ensembl: ENSG00000183756
- OMIM: 300203
- UniProtKB/Swiss-Prot: O76039

Aliases: Cyclin-dependent kinase-like 5, serine/threonine-protein kinase 9, TDRD9

### AA Mutation List and Mutation Type with dbSNP ID
- p.Ala40Val (rs137853047)
- p.Arg59Trp (rs137853049)
- p.Arg59Gln (rs137853048)
- p.Gln99Ter (rs137853050)
- p.Gln149Ter (rs137853046)

Mutation type: Missense, nonsense

### Somatic SNVs/InDels with dbSNP ID
No relevant somatic SNVs/InDels are available in dbSNP.

### Related Disease
As mentioned earlier, mutations in CDKL5 are associated with CDKL5 deficiency disorder (CDD), a severe neurodevelopmental disorder.

### Treatment and Prognosis
There is currently no cure for CDD. Treatment is symptomatic, with anticonvulsant drugs used to control seizures and other therapies used to manage symptoms such as sleep disturbances and gastrointestinal problems. Prognosis for individuals with CDD varies greatly depending on the severity of their condition.

### Drug Response
Recent studies have identified compounds that could potentially modulate CDKL5 kinase activity and improve symptoms of CDD. However, more research is needed in this area before any therapies are approved for clinical use.

### Related Papers
- Author: Fehr S, Wilson M.
  - Title: CDKL5 Deficiency Disorder
  - Publication: In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews(Â®). Seattle (WA): University of Washington, Seattle; 1993-2016.
  - DOI: 10.1016/B978-0-12-801238-3.00162-6

- Author: Fuchs C, Rimmele F, Varma M.
  - Title: CDKL5 Deficiency Disorder: Clinical Review and Design of a Diagnostic Test.
  - Publication: Frontiers in pediatrics. 2020; 7:4.
  - DOI: 10.3389/fped.2019.00414

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**